PubRank

Thomas F Schulz

Author PubWeight™ 65.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat Med 2003 2.61
2 HIV-associated lymphomas and gamma-herpesviruses. Blood 2008 2.27
3 Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest. J Virol 2006 1.68
4 Mother-to-child transmission of human herpesvirus-8 in South Africa. J Infect Dis 2004 1.64
5 Absence of Kaposi's sarcoma-associated herpesvirus in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med 2005 1.55
6 Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1. J Virol 2005 1.51
7 Delayed seroconversion and rapid onset of lymphoproliferative disease after transmission of human T-cell lymphotropic virus type 1 from a multiorgan donor. Clin Infect Dis 2013 1.48
8 Sequences of complete human cytomegalovirus genomes from infected cell cultures and clinical specimens. J Gen Virol 2009 1.39
9 Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration. J Virol 2013 1.34
10 Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions. J Gen Virol 2002 1.34
11 Activation of mitogen-activated protein kinase and NF-kappaB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein. J Virol 2003 1.30
12 Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae. J Gen Virol 2006 1.23
13 Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort study. Transplantation 2009 1.17
14 Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus. J Virol 2006 1.13
15 A Domain in the C-terminal region of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated Herpesvirus affects transcriptional activation and binding to nuclear heterochromatin. J Virol 2003 1.08
16 The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma. J Pathol 2015 1.07
17 Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma. Transplantation 2008 1.06
18 Risk factors for human Herpesvirus 8 infection and AIDS-associated Kaposi's sarcoma among men who have sex with men in a European multicentre study. Int J Cancer 2007 1.06
19 Viral inhibitor of apoptosis vFLIP/K13 protects endothelial cells against superoxide-induced cell death. J Virol 2008 1.05
20 A systems biology approach to identify the combination effects of human herpesvirus 8 genes on NF-kappaB activation. J Virol 2009 1.04
21 Genotypic analysis of two hypervariable human cytomegalovirus genes. J Med Virol 2008 1.04
22 Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome contains a duplication of a long unique-region fragment within the terminal repeat region. J Virol 2011 1.02
23 The interaction of the gammaherpesvirus 68 orf73 protein with cellular BET proteins affects the activation of cell cycle promoters. J Virol 2009 1.01
24 EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX. Blood 2004 1.01
25 KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA. PLoS Pathog 2009 1.01
26 WHAT do viruses BET on? Front Biosci (Landmark Ed) 2010 0.99
27 Risk of rabies infection and adverse effects of postexposure prophylaxis in healthcare workers and other patient contacts exposed to a rabies virus-infected lung transplant recipient. Infect Control Hosp Epidemiol 2007 0.98
28 Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis. AIDS Rev 2004 0.98
29 A structural basis for BRD2/4-mediated host chromatin interaction and oligomer assembly of Kaposi sarcoma-associated herpesvirus and murine gammaherpesvirus LANA proteins. PLoS Pathog 2013 0.96
30 The human cytomegalovirus UL11 protein interacts with the receptor tyrosine phosphatase CD45, resulting in functional paralysis of T cells. PLoS Pathog 2011 0.96
31 Saliva and the transmission of human herpesvirus 8: potential role of promoter-arthropod bites. J Infect Dis 2004 0.93
32 The ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNA. J Virol 2012 0.92
33 Symptomatic hepatitis B virus (HBV) reactivation despite reduced viral fitness is associated with HBV test and immune escape mutations in an HIV-coinfected patient. J Infect Dis 2008 0.92
34 Deletion of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein, vFLIP, from the viral genome compromises the activation of STAT1-responsive cellular genes and spindle cell formation in endothelial cells. J Virol 2011 0.92
35 Kaposi's sarcoma herpesvirus K15 protein contributes to virus-induced angiogenesis by recruiting PLCγ1 and activating NFAT1-dependent RCAN1 expression. PLoS Pathog 2012 0.91
36 Role of the Kaposi's sarcoma-associated herpesvirus K15 SH3 binding site in inflammatory signaling and B-cell activation. J Virol 2010 0.91
37 HHV-8 encoded LANA-1 alters the higher organization of the cell nucleus. Mol Cancer 2007 0.91
38 Influence of HLA alleles on shedding of Kaposi sarcoma-associated herpesvirus in saliva in an African population. J Infect Dis 2007 0.90
39 Use of a BJAB-derived cell line for isolation of human herpesvirus 8. J Clin Microbiol 2005 0.90
40 Human herpesvirus 8: biology and role in the pathogenesis of Kaposi's sarcoma and other AIDS-related malignancies. Curr HIV/AIDS Rep 2004 0.89
41 Characteristics of early and late PTLD development in pediatric solid organ transplant recipients. Transplantation 2013 0.89
42 Functional characterization of the M-type K15-encoded membrane protein of Kaposi's sarcoma-associated herpesvirus. J Gen Virol 2007 0.88
43 HHV-6A in syncytial giant-cell hepatitis. N Engl J Med 2008 0.86
44 Next-generation sequencing fails to identify human virus sequences in cutaneous squamous cell carcinoma. Int J Cancer 2012 0.85
45 The inflammatory kinase MAP4K4 promotes reactivation of Kaposi's sarcoma herpesvirus and enhances the invasiveness of infected endothelial cells. PLoS Pathog 2013 0.84
46 Activation of the B cell antigen receptor triggers reactivation of latent Kaposi's sarcoma-associated herpesvirus in B cells. J Virol 2013 0.83
47 HHV-8 in pulmonary hypertension. N Engl J Med 2004 0.83
48 Abortive lytic reactivation of KSHV in CBF1/CSL deficient human B cell lines. PLoS Pathog 2013 0.83
49 Amino acid residue at position 13 in HLA-DR beta chain plays a critical role in the development of Kaposi's sarcoma in AIDS patients. AIDS 2004 0.83
50 Transmission and disease association of Kaposi's sarcoma-associated herpesvirus: recent developments. Curr Opin Infect Dis 2004 0.83
51 Risk factors for human herpesvirus 8 infection in a cohort of drug users in the Netherlands, 1985-1996. J Infect Dis 2002 0.83
52 A peptide inhibitor of cytomegalovirus infection from human hemofiltrate. Antimicrob Agents Chemother 2013 0.82
53 A role for the internal repeat of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen in the persistence of an episomal viral genome. J Virol 2011 0.81
54 Identification and functional characterization of a spliced rhesus rhadinovirus gene with homology to the K15 gene of Kaposi's sarcoma-associated herpesvirus. J Gen Virol 2009 0.81
55 No human virus sequences detected by next-generation sequencing in benign verrucous skin tumors occurring in BRAF-inhibitor-treated patients. Exp Dermatol 2013 0.81
56 HLA polymorphisms and detection of kaposi sarcoma-associated herpesvirus DNA in saliva and peripheral blood among children and their mothers in the uganda sickle cell anemia KSHV Study. Infect Agent Cancer 2010 0.79
57 The contribution of systems biology and reverse genetics to the understanding of Kaposi's sarcoma-associated herpesvirus pathogenesis in endothelial cells. Thromb Haemost 2009 0.79
58 Changes in T-cell responses against human herpesvirus-8 correlate with the disease course of iatrogenic Kaposi's sarcoma in a patient with undifferentiated arthritis. Semin Arthritis Rheum 2008 0.78
59 Vascular endothelial growth factor levels in serum do not increase following HIV type 1 and HHV8 seroconversion and lack correlation with AIDS-related Kaposi's sarcoma. AIDS Res Hum Retroviruses 2002 0.78
60 Detection of Epstein-Barr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation. J Clin Virol 2009 0.77
61 A rolling circle amplification screen for polyomaviruses other than BKPyV in renal transplant recipients confirms high prevalence of urinary JCPyV shedding. Intervirology 2015 0.76
62 Increased seroprevalence of human herpes virus-8 in renal transplant recipients in Saudi Arabia. Nephrol Dial Transplant 2005 0.76
63 EBV-specific T-cell immunity in pediatric solid organ graft recipients with posttransplantation lymphoproliferative disease. Transplantation 2013 0.75
64 Viremia after lung transplant: a cohort study on risk factors and symptoms associated with detection of Epstein-Barr virus. Prog Transplant 2012 0.75
65 High-level human herpesvirus-8 viremia and multicentric Castleman's disease following initiation of highly active antiretroviral therapy. AIDS 2014 0.75
66 KSHV/HHV-8 infection of tubular epithelial cells in transplantation kidney. Transplantation 2006 0.75
67 Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. Transplantation 2010 0.75